Figure1: Colour coded plasma flow images over 8 slices (1=distal, 8=central) at day 7 after left side SFA excision. Images show significantly higher plasma flow on the ischemic side before angiogenetic therapy. MR perfusion imaging was performed in 8 rabbits with chronic lower limb ischemia after unilateral SFA excision at 3 Tesla (Magnetom Verio, Siemens Healthcare) using a 32-element coil. In 4 animals MRI was performed at day 7 and in 4 animals at day 7 and 35 (after angiogenesis therapy). Multi-slice coverage was provided using a 2D-TurboFLASH technique at 1.5s temporal resolution with repeated measurements over 10min after injection of 0.1mmol/kg gadobutrol (Gadovist, Bayer Schering Pharma). One slice was placed through the aorta for measuring the Arterial Input Function (AIF) and 7 sliced covered the gluteal, thigh and knee musculature. Precontrast T1-mapping was performed using a variable TI GRE technique at identical slice locations (27 steps from 110 ms -5s). Data were post-processed off-line using in-house written software PMI 0.3 including calculation of plasma flow (PF), plasma volume (PV) and extraction flow (EF) based on a 2-compartmental model. T1 mapping data were used to convert signal-time courses to tracer concentration [3]. Results: T1-maps produced robust results on with precontrast T1-values close to typical reference values at 3T. PF was significantly different between the non-ischemic and ischemic limb (14.3±11.5 vs. 8.4±3.9ml/100ml/min) on day 7 (figure 1) whereas there was no significant difference on day 35 after therapy (9.3±2.3 vs. 10.5±3.2 ml/100ml/min). EF showed similar findings with 2.17±1.71 vs. 1.71±1.6 ml/100ml/min on day 7 and 2.3±1.98 vs. 2.15±1.68 ml/100ml/min on day 35. PV did not show significant differences either before or after therapy. Conclusion: Chronic experimental limb ischemia results in significant changes of MR derived perfusion parameters, with reconstitution after experimental therapy. Initial data indicate that perfusion MRI provides a useful tool for the evaluation of muscle ischemia and of therapy effects. PF is significantly reduced in the ischemic leg before therapy and increases again after therapy.
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